Company Tagline
Our platform integrates biology, computation, and engineering to develop impactful antibody-based medicines.
Industry Category
Business Keywords
Company Description
AbCellera is a leading biotechnology research company dedicated to the discovery and development of innovative antibody-based medicines. Located in Vancouver, British Columbia, AbCellera integrates cutting-edge biology, computation, and engineering to create impactful therapies in areas such as endocrinology, women’s health, immunology, and oncology.
With a focus on advancing healthcare solutions, AbCellera utilizes its state-of-the-art platform to accelerate the development of novel therapeutics. The primary address of AbCellera is 150 W 4th Ave, Vancouver, British Columbia V5Y 1G4, CA. Additionally, AbCellera has locations at 41-45 Bourke Rd, Alexandria, New South Wales 2015, AU and 7236 Rue Waverly, Montreal, Quebec H2R 0C2, CA, further expanding its global reach and collaborative efforts.
AbCellera is committed to pushing the boundaries of biotechnology and improving patient outcomes through groundbreaking research and development. We invite the manager of AbCellera to create a customized and exclusive company showcase and product listing on our platform to further highlight their exceptional work.
AbCellera est une entreprise de recherche biotechnologique de premier plan dédiée à la découverte et au développement de médicaments innovants à base d'anticorps. Située à Vancouver, en Colombie-Britannique, AbCellera intègre la biologie, le calcul et l'ingénierie de pointe pour créer des thérapies efficaces dans des domaines tels que l'endocrinologie, la santé des femmes, l'immunologie et l'oncologie.
En mettant l'accent sur l'avancement des solutions de soins de santé, AbCellera utilise sa plateforme de pointe pour accélérer le développement de nouvelles thérapeutiques. L'adresse principale d'AbCellera est 150 W 4th Ave, Vancouver, British Columbia V5Y 1G4, CA. De plus, AbCellera a des bureaux au 41-45 Bourke Rd, Alexandria, New South Wales 2015, AU et au 7236 Rue Waverly, Montréal, Québec H2R 0C2, CA, ce qui élargit encore sa portée mondiale et ses efforts de collaboration.
AbCellera s'engage à repousser les limites de la biotechnologie et à améliorer les résultats pour les patients grâce à la recherche et au développement novateurs. Nous invitons le responsable d'AbCellera à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme afin de mettre en valeur davantage leur travail exceptionnel.
Key Personnel / Employees
Compare Companies Side by Side
Compare AbCellera with 1 companies in Biotechnology-Research
| Comparison Field |
AbCelleraMain Company |
NamocellView Profile |
|---|---|---|
|
Founded Year
|
— | 2014 |
|
Company Size
|
— | 11-50 |
|
City
|
Vancouver, British Columbia | Mountain View, California |
|
Country
|
Canada | United States |
|
Skills & Keywords
Comparing with main company
|
19 Total Skills
Biotechnology
Antibody Discovery
Therapeutics
Oncology
Immunology
Endocrinology
Women’s Health
Antibody Therapies
Cell Recovery
Microfluidic Single Cell Analysis
Single Cell Genomics
Protein engineering
Protein Analysis
T cell engagers
Cell Culture
Bispecifics
Cell Screening
Cell Enrichment
Monoclonal Antibody Discovery
|
14 Total
14 Unique
Unique Skills:
Cell Dispensing
Cell Line Development
Cell Line Engineering
Cell Sorting
CRISPR & Stem Cell Cloning
FACS
+8
|
2
Total Companies2014
Oldest Founded2
Countries33
Unique SkillsSimilar Companies
Other organizations in the same industry
CuraTeQ Biologics
Biotechnology-ResearchImproving access to biosimilars for patients across the globe.
Deciduous Therapeutics
Biotechnology-ResearchDeciduous is developing a novel class of immune-modulatory therapies designed to promote a healthy l...
DD Enterprises
Biotechnology-ResearchSmarter Solutions for Enduring Value
Alternative Company Names
This company is also known as